Asclepieia Medica Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 25 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 853.57%
- Profit Growth 402.64%
- Ebitda 213.21%
- Net Worth 39.50%
- Total Assets 39.37%
About Asclepieia Medica
Asclepieia Medica Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 January 2020 (Five years 25 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Dwivedi and Richa Srivastava serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24234TG2020PTC138526
-
Company No.
138526
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Jan 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Asclepieia Medica?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Dwivedi
|
Managing Director | 20-Jan-2020 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Richa Srivastava
|
Director | 20-Jan-2020 | Current |
Financial Performance of Asclepieia Medica.
Asclepieia Medica Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 853.57% increase. The company also saw a substantial improvement in profitability, with a 402.64% increase in profit. The company's net worth Soared by an impressive increase of 39.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asclepieia Medica?
Unlock access to Asclepieia Medica's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asclepieia Medica?
Unlock and access historical data on people associated with Asclepieia Medica, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asclepieia Medica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asclepieia Medica's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.